methamphetamine and methyllycaconitine

methamphetamine has been researched along with methyllycaconitine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camarasa, J; Chipana, C; Escubedo, E; Pérez-Sánchez, M; Pubill, D1
Camarasa, J; Escubedo, E; Pubill, D; Ratés, SG1
Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Horton, DB; Nickell, JR; Siripurapu, KB; Vartak, A1
Cao, H; Chi, F; Huang, SH; Jong, A; Liu, LQ; Peng, L; Wang, SF; Wu, CH; Yu, JY; Zhang, B1
Huang, SH; Jong, A; Li, L; Liu, L; Mao, DA; Wu, CH; Yu, J; Zhang, B1

Other Studies

5 other study(ies) available for methamphetamine and methyllycaconitine

ArticleYear
Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antioxidants; Blotting, Western; Body Temperature; Body Weight; Calcium; Cell Membrane; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Immunohistochemistry; Isoquinolines; Male; Methamphetamine; Mice; Microglia; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nicotinic Antagonists; Radioligand Assay; Reactive Oxygen Species; Receptors, Nicotinic; Synaptic Vesicles; Synaptosomes; Tyrosine 3-Monooxygenase

2005
The involvement of nicotinic receptor subtypes in the locomotor activity and analgesia induced by methamphetamine in mice.
    Behavioural pharmacology, 2009, Volume: 20, Issue:7

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Dihydro-beta-Erythroidine; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Mice; Motor Activity; Nicotine; Receptors, Nicotinic

2009
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cell Membrane; Conditioning, Operant; Corpus Striatum; Dopamine; Drug Tolerance; Lobeline; Male; Methamphetamine; Nicotine; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins

2010
Alpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factors.
    BMC infectious diseases, 2015, Aug-19, Volume: 15

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Coinfection; Cryptococcus neoformans; HIV Envelope Protein gp41; HIV Infections; HIV-1; Inflammation; Meningitis, Cryptococcal; Methamphetamine; Mice; Mice, Knockout; NF-kappa B; Nicotinic Antagonists

2015
Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine.
    Scientific reports, 2017, 01-11, Volume: 7

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Biomarkers; Blood-Brain Barrier; Brain; Cell Movement; Cellular Senescence; Endothelial Cells; HIV Envelope Protein gp120; HL-60 Cells; Humans; Methamphetamine; Mice, Inbred C57BL; Monocytes; Nicotine; Protein Transport; Receptor for Advanced Glycation End Products; S100 Proteins; Time Factors

2017